Do we understand the pathophysiology of GERD after sleeve gastrectomy?


Journal

Annals of the New York Academy of Sciences
ISSN: 1749-6632
Titre abrégé: Ann N Y Acad Sci
Pays: United States
ID NLM: 7506858

Informations de publication

Date de publication:
12 2020
Historique:
received: 20 04 2020
revised: 20 07 2020
accepted: 23 07 2020
pubmed: 8 9 2020
medline: 2 2 2021
entrez: 7 9 2020
Statut: ppublish

Résumé

Gastroesophageal reflux disease (GERD), a prevalent problem among obese individuals, is strongly associated with obesity and weight loss. Hence, bariatric surgery effectively improves GERD for many patients. Depending on the type of bariatric procedure, however, surgery can also worsen or even cause a new onset of GERD. As a consequence, GERD remains a relevant problem for many bariatric patients, and especially those who have undergone sleeve gastrectomy (SG). Affected patients report not only a decrease in physical functioning but also suffer from mental and emotional problems, resulting in poorer social functioning. The pathomechanism of GERD after SG is most likely multifactorial and triggered by the interaction of anatomical, physiological, and physical factors. Contributing factors include the shape of the sleeve, the extent of injury to the lower esophageal sphincter, and the presence of hiatal hernia. In order to successfully treat post-sleeve gastrectomy GERD, the cause of the problem must first be identified. Therapeutic approaches include lifestyle changes, medication, interventional treatment, and/or revisional surgery.

Identifiants

pubmed: 32893342
doi: 10.1111/nyas.14467
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

26-35

Informations de copyright

© 2020 The Authors. Annals of the New York Academy of Sciences published by Wiley Periodicals, LLC on behalf of New York Academy of Sciences.

Références

Eusebi, L.H., R. Ratnakumaran, Y. Yuan, et al. 2018. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut 67: 430-440.
Vakil, N., S.V. van Zanten, P. Kahrilas, et al. 2006. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am. J. Gastroenterol. 101: 1900-1920; quiz 1943.
Lenderking, W.R., E. Hillson, J.A. Crawley, et al. 2003. The clinical characteristics and impact of laryngopharyngeal reflux disease on health-related quality of life. Value Health 6: 560-565.
Qumseya, B.J., A. Bukannan, S. Gendy, et al. 2019. Systematic review and meta-analysis of prevalence and risk factors for Barrett's esophagus. Gastrointest. Endosc. 90: 707-717.e701.
Findlay, J.M., M.R. Middleton & I. Tomlinson. 2016. Genetic biomarkers of Barrett's esophagus susceptibility and progression to dysplasia and cancer: a systematic review and meta-analysis. Dig. Dis. Sci. 61: 25-38.
Kindel, T.L. & D. Oleynikov. 2016. The improvement of gastroesophageal reflux disease and Barrett's after bariatric surgery. Obes. Surg. 26: 718-720.
Nickel, F., L. Schmidt, T. Bruckner, et al. 2017. Influence of bariatric surgery on quality of life, body image, and general self-efficacy within 6 and 24 months-a prospective cohort study. Surg. Obes. Relat. Dis. 13: 313-319.
Nickel, F., L. Schmidt, T. Bruckner, et al. 2017. Gastrointestinal quality of life improves significantly after sleeve gastrectomy and Roux-en-Y gastric bypass-a prospective cross-sectional study within a 2-year follow-up. Obes. Surg. 27: 1292-1297.
Gu, L., B. Chen, N. Du, et al. 2019. Relationship between bariatric surgery and gastroesophageal reflux disease: a systematic review and meta-analysis. Obes. Surg. 29: 4105-4113.
Peterli, R., B.K. Wolnerhanssen, T. Peters, et al. 2018. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA 319: 255-265.
Peterli, R., B.K. Wolnerhanssen, D. Vetter, et al. 2017. Laparoscopic sleeve gastrectomy versus Roux-Y-gastric bypass for morbid obesity-3-year outcomes of the prospective randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS). Ann. Surg. 265: 466-473.
Ignat, M., M. Vix, I. Imad, et al. 2017. Randomized trial of Roux-en-Y gastric bypass versus sleeve gastrectomy in achieving excess weight loss. Br. J. Surg. 104: 248-256.
Kehagias, I., S.N. Karamanakos, M. Argentou, et al. 2011. Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the management of patients with BMI <50 kg/m2. Obes. Surg. 21: 1650-1656.
Salminen, P., M. Helmio, J. Ovaska, et al. 2018. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA 319: 241-254.
Schauer, P.R., D.L. Bhatt, J.P. Kirwan, et al. 2017. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N. Engl. J. Med. 376: 641-651.
Schauer, P.R., D.L. Bhatt, J.P. Kirwan, et al. 2014. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N. Engl. J. Med. 370: 2002-2013.
Boza, C., D. Daroch, D. Barros, et al. 2014. Long-term outcomes of laparoscopic sleeve gastrectomy as a primary bariatric procedure. Surg. Obes. Relat. Dis. 10: 1129-1133.
DuPree, C.E., K. Blair, S.R. Steele, et al. 2014. Laparoscopic sleeve gastrectomy in patients with preexisting gastroesophageal reflux disease: a national analysis. JAMA Surg. 149: 328-334.
Felsenreich, D.M., G. Prager, R. Kefurt, et al. 2019. Quality of life 10 years after sleeve gastrectomy: a multicenter study. Obes. Facts 12: 157-166.
Biter, L.U., M.M.A. van Buuren, G.H.H. Mannaerts, et al. 2017. Quality of life 1 year after laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass: a randomized controlled trial focusing on gastroesophageal reflux disease. Obes. Surg. 27: 2557-2565.
Carabotti, M., M. Avallone, F. Cereatti, et al. 2016. Usefulness of upper gastrointestinal symptoms as a driver to prescribe gastroscopy in obese patients candidate to bariatric surgery. A prospective study. Obes. Surg. 26: 1075-1080.
Lipan, M.J., J.S. Reidenberg & J.T. Laitman. 2006. Anatomy of reflux: a growing health problem affecting structures of the head and neck. Anat. Rec. B New Anat. 289: 261-270.
Zaninotto, G., T.R. DeMeester, W. Schwizer, et al. 1988. The lower esophageal sphincter in health and disease. Am. J. Surg. 155: 104-111.
Worrell, S.G. & T.R. DeMeester. 2016. Role of LES augmentation for early progressive disease in GERD and fundoplication for end-stage disease in GERD. In Diagnosis and Treatment of Gastroesophageal Reflux Disease. M.F. Vaezi, Ed.: 145-160. Cham: Springer International Publishing.
Hershcovici, T., H. Mashimo & R. Fass. 2011. The lower esophageal sphincter. Neurogastroenterol. Motil. 23: 819-830.
Roman, S., R. Holloway, J. Keller, et al. 2017. Validation of criteria for the definition of transient lower esophageal sphincter relaxations using high-resolution manometry. Neurogastroenterol. Motil. 29. e12920.
Meining, A., A. Fackler, K. Tzavella, et al. 2004. Lower esophageal sphincter pressure in patients with gastroesophageal reflux diseases and posture and time patterns. Dis. Esophagus 17: 155-158.
Wu, J.C., L.M. Mui, C.M. Cheung, et al. 2007. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology 132: 883-889.
Pauwels, A., E. Altan & J. Tack. 2014. The gastric accommodation response to meal intake determines the occurrence of transient lower esophageal sphincter relaxations and reflux events in patients with gastro-esophageal reflux disease. Neurogastroenterol. Motil. 26: 581-588.
Kuo, P., I. Bravi, U. Marreddy, et al. 2013. Postprandial cardiac vagal tone and transient lower esophageal sphincter relaxation (TLESR). Neurogastroenterol. Motil. 25: 841-e639.
Campos, G.M., J.H. Peters, T.R. DeMeester, et al. 1999. The pattern of esophageal acid exposure in gastroesophageal reflux disease influences the severity of the disease. Arch. Surg. 134: 882-887.
Bou Daher, H. & A.I. Sharara. 2019. Gastroesophageal reflux disease, obesity and laparoscopic sleeve gastrectomy: the burning questions. World J. Gastroenterol. 25: 4805-4813.
Braghetto, I., E. Lanzarini, O. Korn, et al. 2010. Manometric changes of the lower esophageal sphincter after sleeve gastrectomy in obese patients. Obes. Surg. 20: 357-362.
Kuper, M.A., K.M. Kramer, A. Kirschniak, et al. 2009. Dysfunction of the lower esophageal sphincter and dysmotility of the tubular esophagus in morbidly obese patients. Obes. Surg. 19: 1143-1149.
Kristo, I., M. Paireder, G. Jomrich, et al. 2019. Modern esophageal function testing and gastroesophageal reflux disease in morbidly obese patients. Obes. Surg. 29: 3536-3541.
Snyder, B., E. Wilson, T. Wilson, et al. 2016. A randomized trial comparing reflux symptoms in sleeve gastrectomy patients with or without hiatal hernia repair. Surg. Obes. Relat. Dis. 12: 1681-1688.
Soricelli, E., A. Iossa, G. Casella, et al. 2013. Sleeve gastrectomy and crural repair in obese patients with gastroesophageal reflux disease and/or hiatal hernia. Surg. Obes. Relat. Dis. 9: 356-361.
Ehlers, A.P., K. Chhabra, J.R. Thumma, et al. 2020. In the eye of the beholder: surgeon variation in intra-operative perceptions of hiatal hernia and reflux outcomes after sleeve gastrectomy. Surg. Endosc. https://doi.org/10.1007/s00464-020-07668-4.
Varban, O.A., J.R. Thumma, D.A. Telem, et al. 2020. Surgeon variation in severity of reflux symptoms after sleeve gastrectomy. Surg. Endosc. 34: 1769-1775.
Petersen, W.V., T. Meile, M.A. Kuper, et al. 2012. Functional importance of laparoscopic sleeve gastrectomy for the lower esophageal sphincter in patients with morbid obesity. Obes. Surg. 22: 360-366.
Mion, F., S. Tolone, A. Garros, et al. 2016. High-resolution impedance manometry after sleeve gastrectomy: increased intragastric pressure and reflux are frequent events. Obes. Surg. 26: 2449-2456.
Del Genio, G., S. Tolone, P. Limongelli, et al. 2014. Sleeve gastrectomy and development of “de novo” gastroesophageal reflux. Obes. Surg. 24: 71-77.
Yehoshua, R.T., L.A. Eidelman, M. Stein, et al. 2008. Laparoscopic sleeve gastrectomy-volume and pressure assessment. Obes. Surg. 18: 1083-1088.
Csendes, A. & I. Braghetto. 2016. Changes in the anatomy and physiology of the distal esophagus and stomach after sleeve gastrectomy. J. Obes. Weight Loss Ther. 6. https://doi.org/10.4172/2165-7904.1000297.
Dhorepatil, A.S., D. Cottam, A. Surve, et al. 2018. Is pneumatic balloon dilation safe and effective primary modality of treatment for post-sleeve gastrectomy strictures? A retrospective study. BMC Surg. 18: 52.
Levy, J.L., M.S. Levine, S.E. Rubesin, et al. 2018. Stenosis of gastric sleeve after laparoscopic sleeve gastrectomy: clinical, radiographic and endoscopic findings. Br. J. Radiol. 91: 20170702.
Burgos, A.M., A. Csendes & I. Braghetto. 2013. Gastric stenosis after laparoscopic sleeve gastrectomy in morbidly obese patients. Obes. Surg. 23: 1481-1486.
Dapri, G., G.B. Cadiere & J. Himpens. 2009. Laparoscopic seromyotomy for long stenosis after sleeve gastrectomy with or without duodenal switch. Obes. Surg. 19: 495-499.
Parikh, A., J.B. Alley, R.M. Peterson, et al. 2012. Management options for symptomatic stenosis after laparoscopic vertical sleeve gastrectomy in the morbidly obese. Surg. Endosc. 26: 738-746.
Rebibo, L., S. Hakim, A. Dhahri, et al. 2016. Gastric stenosis after laparoscopic sleeve gastrectomy: diagnosis and management. Obes. Surg. 26: 995-1001.
Cottam, D., F.G. Qureshi, S.G. Mattar, et al. 2006. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg. Endosc. 20: 859-863.
Zundel, N., J.D. Hernandez, M. Galvao Neto, et al. 2010. Strictures after laparoscopic sleeve gastrectomy. Surg. Laparosc. Endosc. Percutan. Tech. 20: 154-158.
Brethauer, S.A., V. Nfonsam, V. Sherman, et al. 2006. Endoscopy and upper gastrointestinal contrast studies are complementary in evaluation of weight regain after bariatric surgery. Surg. Obes. Relat. Dis. 2: 643-648; discussion 649-650.
Landreneau, J.P., A.T. Strong, J.H. Rodriguez, et al. 2018. Conversion of sleeve gastrectomy to Roux-en-Y gastric bypass. Obes. Surg. 28: 3843-3850.
Lazoura, O., D. Zacharoulis, G. Triantafyllidis, et al. 2011. Symptoms of gastroesophageal reflux following laparoscopic sleeve gastrectomy are related to the final shape of the sleeve as depicted by radiology. Obes. Surg. 21: 295-299.
Werquin, C., J. Caudron, J. Mezghani, et al. 2008. [Early imaging features after sleeve gastrectomy]. J. Radiol. 89: 1721-1728.
Kandeel, A.A., M.D. Sarhan, T. Hegazy, et al. 2015. Comparative assessment of gastric emptying in obese patients before and after laparoscopic sleeve gastrectomy using radionuclide scintigraphy. Nucl. Med. Commun. 36: 854-862.
Garay, M., C. Balague, C. Rodriguez-Otero, et al. 2018. Influence of antrum size on gastric emptying and weight-loss outcomes after laparoscopic sleeve gastrectomy (preliminary analysis of a randomized trial). Surg. Endosc. 32: 2739-2745.
Daes, J., M.E. Jimenez, N. Said, et al. 2012. Laparoscopic sleeve gastrectomy: symptoms of gastroesophageal reflux can be reduced by changes in surgical technique. Obes. Surg. 22: 1874-1879.
Keidar, A., L. Appelbaum, C. Schweiger, et al. 2010. Dilated upper sleeve can be associated with severe postoperative gastroesophageal dysmotility and reflux. Obes. Surg. 20: 140-147.
Spivak, H., M. Rubin, E. Sadot, et al. 2014. Laparoscopic sleeve gastrectomy using 42-French versus 32-French bougie: the first-year outcome. Obes. Surg. 24: 1090-1093.
McGlone, E.R., A.K. Gupta, M. Reddy, et al. 2018. Antral resection versus antral preservation during laparoscopic sleeve gastrectomy for severe obesity: systematic review and meta-analysis. Surg. Obes. Relat. Dis. 14: 857-864.
Matar, R., D. Maselli, E. Vargas, et al. 2020. Esophagitis after bariatric surgery: large cross-sectional assessment of an endoscopic database. Obes. Surg. 30: 161-168.
Felsenreich, D.M., R. Kefurt, M. Schermann, et al. 2017. Reflux, sleeve dilation, and Barrett's esophagus after laparoscopic sleeve gastrectomy: long-term follow-up. Obes. Surg. 27: 3092-3101.
Korenkov, M., L. Kohler, N. Yucel, et al. 2002. Esophageal motility and reflux symptoms before and after bariatric surgery. Obes. Surg. 12: 72-76.
Thereaux, J., T. Lesuffleur, S. Czernichow, et al. 2017. Do sleeve gastrectomy and gastric bypass influence treatment with proton pump inhibitors 4 years after surgery? A nationwide cohort. Surg. Obes. Relat. Dis. 13: 951-959.
Bavishi, C. & H.L. Dupont. 2011. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment. Pharmacol. Ther. 34: 1269-1281.
Leonard, J., J.K. Marshall & P. Moayyedi. 2007. Systematic review of the risk of enteric infection in patients taking acid suppression. Am. J. Gastroenterol. 102: 2047-2056; quiz 2057.
He, B., B. Carleton & M. Etminan. 2019. Risk of gynecomastia with users of proton pump inhibitors. Pharmacotherapy 39: 614-618.
Tai, S.Y., C.Y. Chien, D.C. Wu, et al. 2017. Risk of dementia from proton pump inhibitor use in Asian population: a nationwide cohort study in Taiwan. PLoS One 12: e0171006.
Malfertheiner, P., A. Kandulski & M. Venerito. 2017. Proton-pump inhibitors: understanding the complications and risks. Nat. Rev. Gastroenterol. Hepatol. 14: 697-710.
Parmar, C.D., K.K. Mahawar, M. Boyle, et al. 2017. Conversion of sleeve gastrectomy to Roux-en-Y gastric bypass is effective for gastro-oesophageal reflux disease but not for further weight loss. Obes. Surg. 27: 1651-1658.
Dijkhorst, P.J., A.B. Boerboom, I.M.C. Janssen, et al. 2018. Failed sleeve gastrectomy: single anastomosis duodenoileal bypass or Roux-en-Y gastric bypass? A multicenter cohort study. Obes. Surg. 28: 3834-3842.
Aguilar-Espinosa, F., J. Montoya-Ramirez, J. Gutierrez Salinas, et al. 2020. Conversion to Roux-en-Y gastric bypass surgery through a robotic-assisted hybrid technique after failed sleeve gastrectomy: short-term results. Rev. Gastroenterol. Mex. 85: 160-172.
Casillas, R.A., S.S. Um, J.L. Zelada Getty, et al. 2016. Revision of primary sleeve gastrectomy to Roux-en-Y gastric bypass: indications and outcomes from a high-volume center. Surg. Obes. Relat. Dis. 12: 1817-1825.
Yorke, E., C. Sheppard, N.J. Switzer, et al. 2017. Revision of sleeve gastrectomy to Roux-en-Y gastric bypass: a Canadian experience. Am. J. Surg. 213: 970-974.
Boru, C.E., F. Greco, P. Giustacchini, et al. 2018. Short-term outcomes of sleeve gastrectomy conversion to R-Y gastric bypass: multi-center retrospective study. Langenbecks Arch. Surg. 403: 473-479.
Musella, M., V. Bruni, F. Greco, et al. 2019. Conversion from laparoscopic adjustable gastric banding (LAGB) and laparoscopic sleeve gastrectomy (LSG) to one anastomosis gastric bypass (OAGB): preliminary data from a multicenter retrospective study. Surg. Obes. Relat. Dis. 15: 1332-1339.
Hawasli, A., M. Tarakji & M. Tarboush. 2017. Laparoscopic management of severe reflux after sleeve gastrectomy using the LINX((R)) system: technique and one year follow up case report. Int. J. Surg. Case Rep. 30: 148-151.
Borbely, Y., N. Bouvy, H.G. Schulz, et al. 2018. Electrical stimulation of the lower esophageal sphincter to address gastroesophageal reflux disease after sleeve gastrectomy. Surg. Obes. Relat. Dis. 14: 611-615.
Chang, S.H., V.B. Popov & C.C. Thompson. 2020. Endoscopic balloon dilation for treatment of sleeve gastrectomy stenosis: a systematic review and meta-analysis. Gastrointest. Endosc. 91: 989-1002.e1004.

Auteurs

Eleni Felinska (E)

Department of General, Visceral and Transplant Surgery, University of Heidelberg, Heidelberg, Germany.

Adrian Billeter (A)

Department of General, Visceral and Transplant Surgery, University of Heidelberg, Heidelberg, Germany.

Felix Nickel (F)

Department of General, Visceral and Transplant Surgery, University of Heidelberg, Heidelberg, Germany.

Pietro Contin (P)

Department of General, Visceral and Transplant Surgery, University of Heidelberg, Heidelberg, Germany.

Felix Berlth (F)

Department of General, Visceral and Cancer Surgery, University Hospital of Cologne, Cologne, Germany.

Bipan Chand (B)

Department of Surgery, Loyola University, Chicago, Illinois.

Peter Grimminger (P)

Department of General, Visceral and Transplant Surgery, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.

Dean Mikami (D)

Department of Surgery, John A. Burton School of Medicine, University of Hawaii, Honolulu, Hawaii.

Sebastian F Schoppmann (SF)

Division of General Surgery, Department of Surgery, Medical University of Vienna, Vienna, Austria.

Beat Müller-Stich (B)

Department of General, Visceral and Transplant Surgery, University of Heidelberg, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH